Announcement on Convening the Q3 2024 Performance Briefing
Filed with SSE · · 3 pages · Chinese
Earlier from BeOne Medicines
- Announcement on the Death of the Independent Non-executive Director
- Announcement on the Appointment of Independent Non-executive Directors and Members of Audit Committee of the Board of Directors
- Announcement on the Equity Registration Date for the 1st Extraordinary General Meeting (Shareholders' Special Meeting) in 2024
- Semi-annual Report in 2024
- Announcement on Convening Semi-annual Performance Briefing 2024
Later from BeOne Medicines
- Announcement on Using Partial Extra Raised Funds to Supplement Current Capital Permanently
- Announcement on Proposed Change of Company's English Name
- Announcement on Voluntary Disclosure of the Incorporation of Commercial Products for Multiple Indications into the New Catalogue of Drugs for Basic National Medical Insurance
- Announcement on Voluntary Disclosure of the Change of the Company's NASDAQ Stock Code
- Announcement on the Equity Registration Date for the 1st Extraordinary General Meeting (Shareholders' Special Meeting) in 2025
Follow BeOne Medicines into a list and get an email when it puts out news.
Follow BeOne Medicines